5-Methoxy-2-tetralone>95.0%(GC)1g

2-(9-Oxoxanthen-2-yl)propionic Acid>98.0%(GC)(T)1g

Gefitinib-based PROTAC 3, 5mg

(2-Ethoxy-2-oxoethyl)dimethylsulfonium bromide, 97%, 25g

6-Bromo-4-hydroxyquinolin-2(1H)-one, 95.0%, 25g

Isopropylmethylsulfamoyl chloride, 95.0%, 1g

2-Nitrophenylsulfenyl Chloride [N-Protecting Agent for Peptides Research]>95.0%(GC)(T)100g

5-Bromoquinoline-4-carboxylic acid, 95.0%, 500mg

2-Chloro-5-nitrobenzo[d]oxazole, 95.0%, 5g

(4-Fluoro-3-trifluoromethylphenyl)acetic acid methyl ester, 99.0%, 25g

2-Chloro-n-(2-methyl-1,3-dioxo-2,3-dihydro-1h-isoindol-5-yl)acetamide, 95%, 1g

3,4,5-Trifluorobenzoyl chloride, 97.0%, 5g

N - tert -Butyl-oxalamic acid, 95.0%, 5g